Shawn Green, PhD served as an advisor to early stage life science and wellness platform companies with a focus on plant-based, functional food-derived solutions. Presently, advising on strategies to address nitric oxide deficiencies for the prevention and treatment of age-related chronic diseases and infections.
He created Berkeley Test, the first-patented saliva test for nitric oxide, and invented Berkeley Life, clinically tested nitric oxide supplements to support cardiovascular health.
Dr. Green co-developed second generation nitric oxide nutraceutical, Vascanox, provided by Calroy Health Sciences. New initiatives are underway at MyFitStrip LLC to restore and extend nitric oxide bioavailability for immune support and oral health, including functional nitric oxide chewing gums to enhance the nitric oxide-associated oral microbiome for improving oral-systemic health outcomes. He served on the founder's team as Sr. Vice President of R&D at EntreMed (NASDAQ: CASI), a biotechnology company focused on developing anti-angiogenesis strategies for the treatment of cancer and advanced two drug candidates into clinical trials. Dr. Green co-founded and served as VP of Research at Maxcyte (NASDQ: MXCT; a spin-out of EntreMed) a clinical-stage medical device company focused on cell-based therapeutics. In partnering with IBM Life Sciences John Wiley & Son, Fujitsu, and Itochu, he founded XML Labook, an online bioinformatics platform to integrate and share targeted data for research scientists.
Dr. Green served in the Medical Service Corp at Walter Reed and published the first series of papers on the regulation of nitric oxide and received several life science awards on this work including the Meritorious Service Medal from the US Army. Awarded several patents and published over 100 articles in such journals as, Science, Nature, Nature Medicine, Cancer Research, Journal of Immunology. He served on the editorial board for the American Society of Microbiology and as an editorial reviewer for several biomedical journals. Held academic appointments at Johns Hopkins, Howard, and Catholic and served as a board member for Virginia BIO and as an advisor to Triple Tree, an investment bank in healthcare. Dr. Green received his Ph.D. in Cellular Biology and MBA from Georgetown University.